Aspen Aerogels (NYSE:ASPN) Now Covered by StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Aspen Aerogels (NYSE:ASPN – Get Rating) in a report issued on Friday. The brokerage set a “sell” rating on the construction company’s stock.

Several other equities research analysts have also recently issued reports on the stock. Piper Sandler lowered their target price on shares of Aspen Aerogels from $33.00 to $24.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 22nd. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 17th. Finally, B. Riley lowered their price target on shares of Aspen Aerogels from $39.00 to $26.00 and set a “buy” rating on the stock in a research report on Tuesday, December 13th. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $25.89.

Aspen Aerogels Stock Down 12.9 %

Shares of ASPN stock opened at $6.81 on Friday. Aspen Aerogels has a twelve month low of $6.37 and a twelve month high of $38.04. The stock has a 50 day moving average of $10.50 and a 200 day moving average of $11.17. The company has a current ratio of 1.93, a quick ratio of 1.68 and a debt-to-equity ratio of 0.58.

Aspen Aerogels (NYSE:ASPN – Get Rating) last posted its earnings results on Wednesday, February 15th. The construction company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.12. The firm had revenue of $59.61 million during the quarter, compared to analyst estimates of $57.80 million. Aspen Aerogels had a negative net margin of 45.87% and a negative return on equity of 46.94%. On average, equities research analysts expect that Aspen Aerogels will post -1.35 EPS for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. AIGH Capital Management LLC acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at approximately $11,790,000. Alliancebernstein L.P. raised its position in Aspen Aerogels by 39.0% in the fourth quarter. Alliancebernstein L.P. now owns 17,100 shares of the construction company’s stock worth $202,000 after acquiring an additional 4,800 shares in the last quarter. State of Wisconsin Investment Board raised its position in Aspen Aerogels by 12.6% in the fourth quarter. State of Wisconsin Investment Board now owns 102,372 shares of the construction company’s stock worth $1,207,000 after acquiring an additional 11,420 shares in the last quarter. Legal & General Group Plc increased its position in shares of Aspen Aerogels by 64.4% in the fourth quarter. Legal & General Group Plc now owns 19,597 shares of the construction company’s stock valued at $231,000 after buying an additional 7,679 shares in the last quarter. Finally, Millennium Management LLC increased its position in shares of Aspen Aerogels by 932.0% in the fourth quarter. Millennium Management LLC now owns 1,038,970 shares of the construction company’s stock valued at $12,249,000 after buying an additional 938,293 shares in the last quarter.

Aspen Aerogels Company Profile

(Get Rating)

Aspen Aerogels, Inc engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.